Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Patrick Hurban, Ph.D. | January 27, 2016

Genomics throughout the Drug Development Process

Part three
Genomic technologies can be applied in all phases of the drug development process. In the last of a three-part video series, Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q2 Solutions, discusses the impact of genomic technologies from early research and development and discovery to clinical development.  In addition he explains why the adoption of genomic technologies is important throughout the project lifecycle.
Watch Part one: Precision Medicine – Leveraging Genomics in Clinical Research
Watch Part two: Precision Medicine: Applying Genomics Outside of Oncology


Genomics enhances Clinical Immuno-oncology Trials

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Read More